O'Connor Shirin sold $1.4M of MYRG
O'Connor Shirin sold 3,159 shares of MYR GROUP INC. (MYRG) at an average of $447.19 ($442.35–$452.94, $1.41M total) across 8 trades on 2026-06-01.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider sentiment, which can influence short‑term trading decisions.
Market read
New insider sale information may affect MYRG's short‑term price dynamics.
What to watch
Potential upcoming corporate actions or financing needs that prompted the director's cash requirement.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Director O'Connor Shirin sold 3,159 shares of MYR Group Inc. for $1.4M via open‑market transactions on 2026‑06‑01.
likely slight pressure as the market prices in the director's sell‑off
A $1.4M sale by a director is material enough to attract attention but not large enough to drive a major move; investors often view director sales as a bearish cue.
Market effects
Minimal impact on the broader biotech/health‑care sector; the sale is company‑specific.
No discernible regional effect; the filing is U.S.‑based.
Limited to investors tracking MYR Group; no global market relevance.
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals, so the stock may remain stable.
Key entities
- CompanyMYR Group Inc.
U.S. listed biotech firm (ticker MYRG).
- IndividualO'Connor Shirin
Director of MYR Group who executed the sale.
